Home > Legislation > 115th Congress > H.R.4392

H.R.4392 - To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.115th Congress (2017-2018) |

Bill

Hide Overview
Sponsor: Rep. McKinley, David B. [R-WV-1] (Introduced 11/14/2017)
Committees: House - Energy and Commerce; Ways and Means
Latest Action: House - 11/17/2017 Referred to the Subcommittee on Health.  (All Actions)

Tracker:

This bill has the status Introduced

Here are the steps for Status of Legislation:

  1. Introduced
  2. Passed House
  3. Passed Senate
  4. To President
  5. Became Law

More on This Bill

  • Constitutional Authority Statement
  • CBO Cost Estimates [0]

Subject — Policy Area:

Summary: H.R.4392 — 115th Congress (2017-2018)All Information (Except Text)

There is one summary for H.R.4392. Bill summaries are authored by CRS.

Shown Here:
Introduced in House (11/14/2017)

This bill nullifies a rule finalized by the Centers for Medicare & Medicaid Services on November 13, 2017, that modifies payment under Medicare for certain drugs purchased through the 340B discount program.